|Bid||158.99 x 900|
|Ask||279.00 x 800|
|Day's range||180.59 - 187.50|
|52-week range||180.16 - 285.61|
|Beta (5Y monthly)||1.35|
|PE ratio (TTM)||31.07|
|Earnings date||19 Oct 2022 - 24 Oct 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||267.16|
RESEARCH TRIANGLE PARK, N.C., September 28, 2022--IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and contract services to the life sciences industry, today announced its Decentralized Clinical Trial (DCT) program has received GDPR compliance validation from TRUSTArc. This marks the first instance of a DCT service receiving this European data privacy validation.
Paychex's (PAYX) first-quarter fiscal 2023 earnings and revenues are likely to have surged from the respective year-ago fiscal quarter's levels.
Accenture (ACN) delivered earnings and revenue surprises of 1.17% and 0.17%, respectively, for the quarter ended August 2022. Do the numbers hold clues to what lies ahead for the stock?